Stage I
general19
Centers
0
Active Trials
$565M
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Stage IB | 1 |
Top Centers for Stage I(19)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 69.3 |
| 2 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 67.4 |
| 3 | NCI Comprehensive Active Research Program | 65.4 |
| 4 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 63.5 |
| 5 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 61.5 |
| 6 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 59.6 |
| 7 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 57.6 |
| 8 | NCI Comprehensive Active Research Program | 55.7 |
| 9 | Loma Linda University Cancer CenterLoma Linda, CA Active Research Program | 53.8 |
| 10 | NCI Comprehensive Active Research Program | 51.8 |
| 11 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 49.9 |
| 12 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 47.9 |
| 13 | Boston University Cancer CenterBoston, MA Active Research Program | 46.0 |
| 14 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 44.0 |
| 15 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 42.1 |
| 16 | NCI Comprehensive Active Research Program | 40.1 |
| 17 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 38.2 |
| 18 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 36.3 |
| 19 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →